LIRAMETOSTAT

UNII:	455J2479FY
Type:	INGREDIENT SUBSTANCE
Formula:	C₂₇H₃₃F₃N₄O₃
Preferred Substance Name:	LIRAMETOSTAT
InChIKey:	HPODOLXTMDHLLC-QGZVFWFLSA-N
GSRS Full Record:	455J2479FY i

1621862-70-1
(R)-N-((4-METHOXY-6-METHYL-2-OXO-1,2-DIHYDROPYRIDIN-3-YL)METHYL)-2-METHYL-1-(1-(1-(2,2,2-TRIFLUOROETHYL)PIPERIDIN-4-YL)ETHYL)-1H-INDOLE-3-CARBOXAMIDE
1H-INDOLE-3-CARBOXAMIDE, N-((1,2-DIHYDRO-4-METHOXY-6-METHYL-2-OXO-3-PYRIDINYL)METHYL)-2-METHYL-1-((1R)-1-(1-(2,2,2-TRIFLUOROETHYL)-4-PIPERIDINYL)ETHYL)-
CPI-1205
EZH2 INHIBITOR CPI-1205
Lirametostat [WHO-DD]
N-[(4-methoxy-6-methyl-2-oxo-1H-pyridin-3-yl)methyl]-2-methyl-1-[(1R)-1-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]ethyl]indole-3-carboxamide
lirametostat [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

LIRAMETOSTAT

Synonyms and Mappings

Resources